ANCA in the diagnosis of neutrophil-mediated inflammation

Autoimmunity Reviews

Volumn 10, Issue 6, 2011, Pages 295-298

  Lochman, Ivo ^a   Král, Vlastimil ^a   Lochmanová, Alexandra ^b   LupaC, Julius ^c   Cebecauer, Ladislav ^d  

^a Zdravotniho ustavu se sidlem v Ostrave   (Czech Republic)

^b Dept Examination Methods and Medical Biology   (Czech Republic)

^c Dynex Ltd   (Czech Republic)

^d Laboratories Pie Cany Ltd   (Slovakia)

Author keywords

ANCA terminology; NSA; Vasculitis and other neutrophil mediated inflammatory diseases

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CATHEPSIN; ELASTASE; LACTOFERRIN; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

CONNECTIVE TISSUE DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE; HUMAN; IMMUNOFLUORESCENCE; INFLAMMATION; NEUTROPHIL; NONHUMAN; REVIEW; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; HUMANS; INFLAMMATION; NEUTROPHILS; TERMINOLOGY AS TOPIC;

EID: 79953163280     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.11.003     Document Type: Review

References (25)

1. Calabresi P., Edwards E.A., Schilling R.F. Fluorescent antiglobulin studies in leukopenic and related disorders. J Clin Invest 1959, 38:2091-2100.
2. Davies D.J., Moran J.E., Naill J.F., Ryan G.B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aethiology?. Br Med J 1982, 285:606.
3. Van der Woulde F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985, 1:425-429.
4. Kallenberg C.G.M. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase. autoantibodies 2007, 95-103. Elsevier, Amsterodam · Boston · Heidelberg · London · New York · Oxford · Paris · San Diego · San Francisco · Singapore · Sydney · Tokyo, 10: 0-444-52763-X. second ed. Y. Shoenfeld, M.E. Gershwin, P.L. Meroni (Eds.).
5. Hu N., Westra J., Kallenberg C.G. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's granulomatosis. Autoimmun Rev 2009, 8:510-514.
6. Kallenberg C.G., Tadema H. Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "autoimmunity and infection". Autoimmun Rev 2008, 8:29-32.
7. Chen M., Kallenberg C.G.M. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2010, 9:A293-A298.
8. Wiik A.S. Autoantibodies in ANCA-associated vasculitis. Rheum Dis Clin N Am 2010, 36:479-489.
9. Terjung B., Spengler U., Sauerbruch T., Worman H.J. Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000, 119:310-322.
10. Terjung B., Spengler U. Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?. Clin Rev Allergy Immunol 2009, 36:40-51.
11. Wiik A. Neutrophil-specific antinuclear and anti-cytoplasmic antibodies in chronic inflammatory diseases. Autoantibodies 2007, 111-117. Elsevier, Amsterodam · Boston · Heidelberg · London · New York · Oxford · Paris · San Diego · San Francisco · Singapore · Sydney · Tokyo, 10: 0-444-52763-X. second ed. Y. Shoenfeld, M.E. Gershwin, P.L. Meroni (Eds.).
12. Cohen Tervaert J.W., Damoiseaux J. Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA?. APMIS 2009, 117:55-59.
13. Savige J., Dimech W., Fritzler M., Gieken J., Hagen E.C., Jennette J.C., et al. Addendum to International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other immune diseases. Am J Clin Pathol 2003, 120:312-318.
14. Wiik A. Granulocyte-specific antinuclear antibodies. Possible significance for pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy 1980, 35:263-289.
15. Skogh T., Dahlgren C., Holmgren K., Peen E., Stendahl O. Anti-granulocyte antibodies (C-ANCA, P-ANCA, GS-ANA) studied by confocal scanning laser fluorescence microscopy, ELISA, and chemiluminescence techniques. Scand J Immunol 1991, 34:137-145.
16. Cebecauer L., Král V., Lupač J., Lochman I. ANCA or other neutrophil specific antibodies (NSA). Autoantigens, Autoantibodies, Autoimmunity 2009, 6:378-379. PABST, Lengerich, Berlin, Bremen, Miami, Riga, Viernheim, Wien, Zagreb, 978-3-899067-579-5. K. Conrad, E.K.L. Chan, M.J. Fritzle, R.L. Humbel, P. von Landenberg, Y. Shoenfeld (Eds.).
17. Laboratory ANCA diagnostics Methodical recommendation and guideline of SLI ČSAKI. Alergie 2005, 7:57-58. (In Czech).
18. Falk R., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651-1657.
19. Yang J.J., Tuttle R.H., Hogan S.L., Taylor J.G., Phillip B.D., Falk R.J., et al. Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol 2000, 121:165-172.
20. Radice A., Sabadini E., Sinicii R.A. Antineutrophil cytoplasmic autoantibodies with specificity for proteinase 3. autoantibodies 2007, 105-110. Elsevier, Amsterodam • Boston • Heidelberg • London • New York · Oxford · Paris · San Diego · San Francisco · Singapore · Sydney · Tokyo, 10: 0-444-52763-X. second ed. Y. Shoenfeld, M.E. Gershwin, P.L. Meroni (Eds.).
21. Wiik A. Antineutrophil Cytoplasm Antibodies (ANCAs) and Strategy for Diagnosing ANCA-Associated Vasculities. Manual of Molecular and Clinical Laboratory Immunology 2006, 1053-1058. ASM Press, Washington, D.C, 10: 1-55581-364-X. seventh ed. B. Detrick, R.G. Hamilton, J.D. Folds (Eds.).
22. Wiik A. Rational use of ANCA in the diagnosis of vasculitis. Rheumatology 2002, 41:481-483.
23. Vassilopoulos D., Hoffman G.S. Clinical utility of testing for antineutrophil cytoplasmic antibodies. Clin Diagn Lab Immunol 1999, 6:645-651.
24. Drooger J.C., Dees A., Swaak A.J. ANCA-Positive patients: the influence of PR3 and MPO antibodies on survival rate and the association with clinical and laboratory characteristics. Open Rheumatol J 2009, 3:14-17.
25. Teegen B., Niemann S., Probst C., Schlumberger W., Stöcker W., Komorowski L. DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis. Ann NY Acad Sci 2009, 1173:161-165.